Dexcom G6 is now covered by RAMQ, BC PharmaCare, and Saskatchewan Health
The Dexcom G6 CGM System is now covered in Québec by RAMQ, in British Columbia by BC PharmaCare, and in Saskatchewan by Saskatchewan Health. Conditions apply. Click the links below for more information.
Putting the power of continuous glucose readings in the hands of patients and their healthcare teams – which helps improve diabetes management, increase treatment satisfaction, and improve quality of life.
Inserted just underneath the skin with a simple one-touch applicator, the sensor measures interstitial glucose levels.
The transmitter sends data wirelessly to a display device.
An Apple or Android compatible smart device§ or touch screen receiver displays real-time glucose data, and allows patient data uploads to Dexcom CLARITY¶.
Smart device not included
“Dexcom G6 is technology that empowers people with diabetes. As a Paediatric Endocrinologist, I know the fear parents have of unrecognized hypoglycemia. This technology makes me a better doctor by providing the information needed to fine tune insulin therapy to meet the needs of my patients.”
Dr. Angelo Simone | Pediatric Endocrinologist
Dr. Simone is a spokesperson of Dexcom Canada, Co.
With Dexcom CLARITY software, you can have ongoing visibility into your patients’ data.
This will enable you and your team to evaluate patients' glucose patterns, analyze data
and diabetes management plans – all from your clinic computer.
• Invite patients to share their data for quick access and efficient visits
• Access all your patients’ data in one easy-to-use clinic portal with 8 interactive reports
§ For a list of compatible devices, please visit dexcom.com/compatibility. Use of the smart watch requires the Dexcom G6 App on a compatible smartphone.
¶ An internet connection is required to send data to Dexcom CLARITY.
1 Beck RW, et al. JAMA 2017;317:371-8.
2 Beck RW, et al. Lancet Diabetes Endocrinol 2017;5:700-8.
3 Reddy M, et at. Diabet Med 2018;35:483-90.
4 Reddy M, et al. Diabetes Technol Ther 2018;20 :751-57.
5 Heinemann L, et al. Lancet 2018;391 :1367-77.
6 Ólafsdóttir AF, et al. Diabetes Technol Ther 2018; 20 :274 – 84.
7 Riddlesworth T, et al. Diabetes Ther 2017;8 :947-51.